IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (6)
Leerink Partners
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3 | Xencor Inc | Health-Care | 5.5 | 12 | CS | LRNK | 14.7% | 51.6% | |||
| Nov 6 | Karyopharm Ther | Health-Care | 16 | 6 | BAML | LRNK | MS | 87.5% | 0.3% | ||
| Oct 30 | Veracyte Inc | Health-Care | 13 | 5 | LRNK | MS | 91.9% | 1.9% | |||
| Oct 10 | MacroGenics Inc | Health-Care | 16 | 5 | BAML | LRNK | 107.2% | 56.2% | |||
| Jul 25 | Onconova Therap | Health-Care | 15 | 5 | CITI | LRNK | 0.7% | 98.7% | |||
| May 31 | Epizyme Inc | Health-Care | 15 | 5 | CITI | COWN | LRNK | 63.9% | 53.3% | ||
*
Lead manager or one of top three managers in an underwriting team.